According to our current knowledge the most likely scenario is that AITC treatment causes ROS production 19,20 and induces the expression of several GSTs 17,40,41 as part of the plants detoxification system to conjugate AITC to glutathione leading to its intracellular depletion
Whether your work involves benchtop screening, in-vivo model validation, or comparative pharmacology, the consistent quality of FOXO4-DRI from Biotech Peptides removes one of the largest variables in peptide research: starting-material integrity
Not all peptides used in wellness settings are FDA-approved for every purpose they may be discussed for
Quality-focused production standards, analytical evaluation support, and third-party testing where applicable
No new or unexpected safety signals emerged from the Phase 3 data that had not already been identified in Phase 2